Meszarosova Anna Uhrova, Seeman Pavel, Jencik Jan, Drabova Jana, Cibochova Renata, Stellmachova Julia, Safka Brozkova Dana
DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine Charles University and University Hospital Motol, Prague, Czech Republic.
DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine Charles University and University Hospital Motol, Prague, Czech Republic.
Neurosci Lett. 2020 Mar 16;721:134800. doi: 10.1016/j.neulet.2020.134800. Epub 2020 Jan 30.
Hereditary spastic paraplegia (HSP or SPG) is a group of rare upper motor neuron diseases. As some ethnically-specific, disease-causing homozygous variants were described in the Czech Roma population, we hypotesised that some prevalent HSP-causing variant could exist in this population. Eight Czech Roma patients were found in a large group of Czech patients with suspected HSP and were tested using gene panel massively parallel sequencing (MPS). Two of the eight were diagnosed with SPG11 and SPG77, respectively. The SPG77 patient manifests a pure HSP phenotype, which is unusual for this SPG type. Both patients are compound heterozygotes for two different variants in the SPG11 (c.1603-1G>A and del ex. 16-18) and FARS2 (c.1082C>T and del ex.1-2) genes respectively; the three variants are novel. In order to find a potential ethnically-specific, disease-causing variant for HSP, we tested the heterozygote frequency of these variants among 130 anonymised DNA samples of Czech Roma individuals without clinical signs of HSP (HPS-negative). A novel deletion of ex.16-18 in the SPG11 gene was found in a heterozygous state in one individual in the HSP-negative group. Haplotype analysis showed that this individual and the patient with SPG11 shared the same haplotype. This supports the assumption that the identified SPG11 deletion could be a founder mutation in the Czech Roma population. In some Roma patients the disease may also be caused by two different biallelic pathogenic mutations.
遗传性痉挛性截瘫(HSP或SPG)是一组罕见的上运动神经元疾病。由于在捷克罗姆人群体中描述了一些特定种族的致病纯合变异,我们推测该群体中可能存在一些常见的导致HSP的变异。在一大群疑似患有HSP的捷克患者中发现了8名捷克罗姆患者,并使用基因panel大规模平行测序(MPS)进行检测。这8名患者中有2名分别被诊断为SPG11和SPG77。SPG77患者表现出纯HSP表型,这在该SPG类型中并不常见。两名患者分别是SPG11(c.1603 - 1G>A和外显子16 - 18缺失)和FARS2(c.1082C>T和外显子1 - 2缺失)基因中两种不同变异的复合杂合子;这三种变异都是新发现的。为了找到一种潜在的特定种族的、导致HSP的致病变异,我们在130份无HSP临床症状(HPS阴性)的捷克罗姆个体的匿名DNA样本中检测了这些变异的杂合子频率。在HSP阴性组的一名个体中发现了SPG11基因外显子16 - 18的一种新缺失,且该个体处于杂合状态。单倍型分析表明,该个体与SPG11患者共享相同的单倍型。这支持了所鉴定的SPG11缺失可能是捷克罗姆人群体中的奠基者突变这一假设。在一些罗姆患者中,疾病也可能由两种不同的双等位基因致病突变引起。